ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

224
Analysis
Health Care • Australia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
bullish•Minmetals Land
•24 Oct 2025 08:53

Minmetals Land (230 HK): An Offer Premium Of 179% To NAV? Yes Please

Clean deal. If small-cap illiquid arbs are your bent get involved here. I'd pay up to HK$0.95/share, assuming end of February 2026 payment.

Logo
592 Views
Share
•23 Oct 2025 14:54

IDT (167 HK): Expect Long-Dated MGO As Major Shareholder Placed In Receivership

Consumer electronics play IDT International (167 HK) is currently suspended pursuant to the Takeovers Code. But don't expect your usual Offer to...

Logo
756 Views
Share
bullish•ENN Energy
•20 Oct 2025 01:41

Merger Arb Mondays (20 Oct) - ENN Energy, Joy City, Kangji, Mandarin, Soft99, Mandom, Makino

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
742 Views
Share
bullish•Hang Seng Bank
•19 Oct 2025 06:30

Last Week In Event SPACE: Hang Seng, Welcia/Tsuruha, HKT, Genting, Daiichi, Aussie Rare Earths

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
464 Views
Share
bullish•Kangji Medical
•19 Oct 2025 06:15

(Mostly) Asia-Pac M&A: Mandarin Oriental, RPMGlobal, Genting, Mayne Pharma, Iress, Kangji Medical

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
728 Views
Share
x